Abstract 3914: Tcfap2c regulates growth and oncogenesis in neu-activated breast cancer
Abstract TFAP2C and mouse homolog tcfap2c are transcription factors that play a critical role in mammary gland development and in maintaining the luminal breast cancer phenotype. Interestingly, several human HER2-positive breast cancer cell lines display genetic dependency on TFAP2C. However, the ro...
Saved in:
Published in | Cancer research (Chicago, Ill.) Vol. 74; no. 19_Supplement; p. 3914 |
---|---|
Main Authors | , , , , , , , |
Format | Journal Article |
Language | English |
Published |
01.10.2014
|
Online Access | Get full text |
Cover
Loading…
Abstract | Abstract
TFAP2C and mouse homolog tcfap2c are transcription factors that play a critical role in mammary gland development and in maintaining the luminal breast cancer phenotype. Interestingly, several human HER2-positive breast cancer cell lines display genetic dependency on TFAP2C. However, the role of TFAP2C in carcinogenesis and progression in neu-activated breast cancer remains unknown. We examined the role of tcfap2c in mammary gland carcinogenesis by examining tumor formation in mice expressing an activated rat neu gene using MMTV-neu with and without mammary gland conditional knockout (KO) of tcfap2c using MMTV-Cre. The time until spontaneous palpable tumor formation was measured in mice harboring the neu oncogene with and without tcfap2c. Mice with homozygous conditional deletion of tcfap2c demonstrated a significant delay in tumor formation compared to littermate controls that retained tcfap2c expression (42 vs. 25 weeks, p<0.004). Immunohistochemistry of the tumors demonstrated a luminal phenotype; cytokeratin 8 (CK8), a luminal marker, was more strongly expressed compared to cytokeratin 5 (CK5), a basal marker, in tumors from both control (883 vs. 0.1 cells/HPF, p<0.0005) and KO animals (845 vs. 0, p<0.0005). Cleaved caspase-3 (CC3) showed that apoptosis was increased in tumors from KO compared to control animals (5 vs. 0.3 CC3-positive cells/HPF, p<0.0008). Ki-67 showed that proliferation was decreased in KO compared to control (348 vs. 142 cells/HPF, p<0.009). To validate the effects of tcfap2c, we established a cell line from a tumor obtained from an animal expressing activated neu with homozygous floxed tcfap2c lacking Cre expression. Paired cell lines with differential expression of tcfap2c were established by infecting the cells with Adenovirus-Cre (Ad-Cre) or Adenovirus-Empty (Ad-Empty). Proliferation was assessed by MTT and demonstrated that loss of tcfap2c expression resulted in a 30% decrease in proliferation rate (p<0.006). The difference in proliferation was confirmed in vivo through xenograft experiments of these paired cell lines inoculated into athymic (nude) mice. Mice xenografted with the paired cell lines demonstrated that KO of tcfap2c resulted in a significant delay in tumors reaching a 2 cm threshold requiring euthanasia (27.8 vs. 19.8 days post-inoculation, p<0.003). In order to identify a potential mechanism accounting for the differences in proliferation and delay in carcinogenesis, we identified tcfap2c target genes by comparing the binding sites of tcfap2c by chromatin-immunoprecipitation-sequencing (ChIP-seq) and differential expression by microarray/RT-PCR. We identified erbb3 and egfr as two tcfap2c target genes by ChIP-seq. KO of tcfap2c resulted in a 3-fold and 12-fold reduction in erbb3 and egfr expression, respectively (p<0.05). Taken together, these findings indicate that tcfap2c plays critical roles in oncogenesis and progression of HER2-positive mammary cancer.
Citation Format: Jung M. Park, Tong Wu, George Woodfield, Anthony Cyr, James De Andrade, Weizhou Zhang, Frederick Domann, Ronald J. Weigel. Tcfap2c regulates growth and oncogenesis in neu-activated breast cancer. [abstract]. In: Proceedings of the 105th Annual Meeting of the American Association for Cancer Research; 2014 Apr 5-9; San Diego, CA. Philadelphia (PA): AACR; Cancer Res 2014;74(19 Suppl):Abstract nr 3914. doi:10.1158/1538-7445.AM2014-3914 |
---|---|
AbstractList | Abstract
TFAP2C and mouse homolog tcfap2c are transcription factors that play a critical role in mammary gland development and in maintaining the luminal breast cancer phenotype. Interestingly, several human HER2-positive breast cancer cell lines display genetic dependency on TFAP2C. However, the role of TFAP2C in carcinogenesis and progression in neu-activated breast cancer remains unknown. We examined the role of tcfap2c in mammary gland carcinogenesis by examining tumor formation in mice expressing an activated rat neu gene using MMTV-neu with and without mammary gland conditional knockout (KO) of tcfap2c using MMTV-Cre. The time until spontaneous palpable tumor formation was measured in mice harboring the neu oncogene with and without tcfap2c. Mice with homozygous conditional deletion of tcfap2c demonstrated a significant delay in tumor formation compared to littermate controls that retained tcfap2c expression (42 vs. 25 weeks, p<0.004). Immunohistochemistry of the tumors demonstrated a luminal phenotype; cytokeratin 8 (CK8), a luminal marker, was more strongly expressed compared to cytokeratin 5 (CK5), a basal marker, in tumors from both control (883 vs. 0.1 cells/HPF, p<0.0005) and KO animals (845 vs. 0, p<0.0005). Cleaved caspase-3 (CC3) showed that apoptosis was increased in tumors from KO compared to control animals (5 vs. 0.3 CC3-positive cells/HPF, p<0.0008). Ki-67 showed that proliferation was decreased in KO compared to control (348 vs. 142 cells/HPF, p<0.009). To validate the effects of tcfap2c, we established a cell line from a tumor obtained from an animal expressing activated neu with homozygous floxed tcfap2c lacking Cre expression. Paired cell lines with differential expression of tcfap2c were established by infecting the cells with Adenovirus-Cre (Ad-Cre) or Adenovirus-Empty (Ad-Empty). Proliferation was assessed by MTT and demonstrated that loss of tcfap2c expression resulted in a 30% decrease in proliferation rate (p<0.006). The difference in proliferation was confirmed in vivo through xenograft experiments of these paired cell lines inoculated into athymic (nude) mice. Mice xenografted with the paired cell lines demonstrated that KO of tcfap2c resulted in a significant delay in tumors reaching a 2 cm threshold requiring euthanasia (27.8 vs. 19.8 days post-inoculation, p<0.003). In order to identify a potential mechanism accounting for the differences in proliferation and delay in carcinogenesis, we identified tcfap2c target genes by comparing the binding sites of tcfap2c by chromatin-immunoprecipitation-sequencing (ChIP-seq) and differential expression by microarray/RT-PCR. We identified erbb3 and egfr as two tcfap2c target genes by ChIP-seq. KO of tcfap2c resulted in a 3-fold and 12-fold reduction in erbb3 and egfr expression, respectively (p<0.05). Taken together, these findings indicate that tcfap2c plays critical roles in oncogenesis and progression of HER2-positive mammary cancer.
Citation Format: Jung M. Park, Tong Wu, George Woodfield, Anthony Cyr, James De Andrade, Weizhou Zhang, Frederick Domann, Ronald J. Weigel. Tcfap2c regulates growth and oncogenesis in neu-activated breast cancer. [abstract]. In: Proceedings of the 105th Annual Meeting of the American Association for Cancer Research; 2014 Apr 5-9; San Diego, CA. Philadelphia (PA): AACR; Cancer Res 2014;74(19 Suppl):Abstract nr 3914. doi:10.1158/1538-7445.AM2014-3914 |
Author | Weigel, Ronald J. Cyr, Anthony Wu, Tong Woodfield, George Andrade, James De Park, Jung M. Zhang, Weizhou Domann, Frederick |
Author_xml | – sequence: 1 givenname: Jung M. surname: Park fullname: Park, Jung M. – sequence: 2 givenname: Tong surname: Wu fullname: Wu, Tong – sequence: 3 givenname: George surname: Woodfield fullname: Woodfield, George – sequence: 4 givenname: Anthony surname: Cyr fullname: Cyr, Anthony – sequence: 5 givenname: James De surname: Andrade fullname: Andrade, James De – sequence: 6 givenname: Weizhou surname: Zhang fullname: Zhang, Weizhou – sequence: 7 givenname: Frederick surname: Domann fullname: Domann, Frederick – sequence: 8 givenname: Ronald J. surname: Weigel fullname: Weigel, Ronald J. |
BookMark | eNqdj9FKAzEQRUNpoVv1E4T5gdRkN6HbvhVRfPGt9DWk6ex2pSZlJlX8ezcofoBPl7nMgXMXYhpTRCHutVpqbdsHbZtWroyxy-1rrbSRzVqbiaj--qmolFKttGZVz8WC-W08rVa2EvvtgTP5kKFAG9iFzl_qAIT99ewzMvSUPvMJfDxCiiH1GJEHhiFCxKscyeFj_DvCgdBzhuBjQLoVs86fGe9-80bY56fd44sMlJgJO3eh4d3Tl9PKlRGuyLoi635GuOLT_Jf7Bmq5Ufs |
ContentType | Journal Article |
DBID | AAYXX CITATION |
DOI | 10.1158/1538-7445.AM2014-3914 |
DatabaseName | CrossRef |
DatabaseTitle | CrossRef |
DatabaseTitleList | CrossRef |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
EISSN | 1538-7445 |
EndPage | 3914 |
ExternalDocumentID | 10_1158_1538_7445_AM2014_3914 |
GroupedDBID | --- -ET 18M 29B 2WC 34G 39C 476 53G 5GY 5RE 5VS 6J9 AAYXX ABOCM ACGFO ACIWK ACPRK ACSVP ADBBV ADCOW ADNWM AENEX AFHIN AFOSN AFRAH ALMA_UNASSIGNED_HOLDINGS BAWUL BTFSW CITATION CS3 DIK DU5 EBS EJD F5P FRP GX1 H13 IH2 KQ8 L7B LSO OK1 P0W P2P PQQKQ RCR RHF RHI RNS SJN TR2 W2D W8F WH7 WOQ YKV YZZ |
ID | FETCH-crossref_primary_10_1158_1538_7445_AM2014_39143 |
ISSN | 0008-5472 |
IngestDate | Thu Sep 26 18:07:10 EDT 2024 |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 19_Supplement |
Language | English |
LinkModel | OpenURL |
MergedId | FETCHMERGED-crossref_primary_10_1158_1538_7445_AM2014_39143 |
ParticipantIDs | crossref_primary_10_1158_1538_7445_AM2014_3914 |
PublicationCentury | 2000 |
PublicationDate | 2014-10-01 |
PublicationDateYYYYMMDD | 2014-10-01 |
PublicationDate_xml | – month: 10 year: 2014 text: 2014-10-01 day: 01 |
PublicationDecade | 2010 |
PublicationTitle | Cancer research (Chicago, Ill.) |
PublicationYear | 2014 |
SSID | ssj0005105 |
Score | 4.353206 |
Snippet | Abstract
TFAP2C and mouse homolog tcfap2c are transcription factors that play a critical role in mammary gland development and in maintaining the luminal... |
SourceID | crossref |
SourceType | Aggregation Database |
StartPage | 3914 |
Title | Abstract 3914: Tcfap2c regulates growth and oncogenesis in neu-activated breast cancer |
Volume | 74 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1LS8NAEF5qBfEiPvHNHryFxD6yTeKtiCKVikKV3sJmu6mFkpSaCPqL_JnOPpKsWsR6Ce1CptvMx-zM5JsZhM4IjRtxh1K74XvMdl2P2xFl1GYQTLRoRAnjot65f9e5eXR7QzKs1T4M1lKeRQ57X1hX8h-twhroVVTJLqHZUigswGfQL1xBw3D9k467kUhUsMxqB01XJspZTGct0ZRZTpjnL9YYwmxdvZYmLB0L0zaRHNiE57aoanilwumMBDk9Exwwpvm6VfsCWLF0U6Bn-dZX0TekeZlOHSOZcK-Z1z0wIVbfKS1-LmGR6lNSMoHTUTkdW-Xly7chb3Ojq4GZlWi6Jb-tsrS-TVw1lsfhlXH1XNU-srC-akZPgbIglMNMK9aPMqviKRpHdPH1p_knoqSh_B2n25d7q243221_OwZLcqIMi4gfCjGhEBMqMaEQs4JWW15ABHn09qHqS080Wbb417pWDMScL9yN4QUZ7sxgE23oOAR3Fai2UI0n22itr5kWO-ipwBYWgi6wRhYukYUVsjAgCxvIwpMEf0EWVsjCClm7iFxfDS5v7GJf4Uy1Owl_fR7tPVRP0oTvI-xT8BdHAYWAg7rtUTMC35zHcgRrB8ISdoCc5WQfLnvDEVqvsHiM6tk85yfgM2bRqVTXJ-gJZjo |
link.rule.ids | 315,786,790,27955,27956 |
linkProvider | Colorado Alliance of Research Libraries |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Abstract+3914%3A+Tcfap2c+regulates+growth+and+oncogenesis+in+neu-activated+breast+cancer&rft.jtitle=Cancer+research+%28Chicago%2C+Ill.%29&rft.au=Park%2C+Jung+M.&rft.au=Wu%2C+Tong&rft.au=Woodfield%2C+George&rft.au=Cyr%2C+Anthony&rft.date=2014-10-01&rft.issn=0008-5472&rft.eissn=1538-7445&rft.volume=74&rft.issue=19_Supplement&rft.spage=3914&rft.epage=3914&rft_id=info:doi/10.1158%2F1538-7445.AM2014-3914&rft.externalDBID=n%2Fa&rft.externalDocID=10_1158_1538_7445_AM2014_3914 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0008-5472&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0008-5472&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0008-5472&client=summon |